FLAGSTAFF, Ariz. and LONDON, England (April 24, 2014) – W. L. Gore & Associates (Gore) joined with leaders across the vascular and endovascular community in honoring four European physicians as Pioneers in Performance. The biennial award acknowledges exceptional work in the field of vascular and endovascular therapy, including aortic and lower-limb bypass and dialysis access surgery.

The 2014 nominees were selected by past award recipients in four categories that correspond with different aspects of clinical collaboration. Through popular vote on www.pioneersinperformance.com, the broader medical community chose to award the following honorees at a special celebration during the 36th Charing Cross International Symposium held in London, April 5-8, 2014.

Commitment to Ongoing Learning:

• Krassi Ivancev, MD, PhD, Professor and Head of the Complex Endovascular Aneurysm Treatment Team at The Royal Free Hospital, London, United Kingdom

Dedication to Sharing Knowledge with Peers and Patients:

• Dierk Vorwerk, MD, Chairman of the Department of Diagnostic and Interventional Radiology at Ingolstadt Hospital, Ingolstadt, Germany

Dedication to Creating Consensus within the Medical Community:

• Fabrizio Fanelli, MD, Professor of Interventional Radiology at the University of Rome La Sapienza, Rome, Italy

Dedication to Analysis of Clinical Outcomes:

• Jim A. Reekers, MD, Professor of Interventional at the Academic Medical Center, Amsterdam, Netherlands

Professor Roger Greenhalgh, a past recipient of the award, commented, “Pioneers in Performance celebrates the incredible achievements made by proven leaders in our field by honoring their dedication to excellence through innovation, critical thinking, education, research, and collaboration. This year’s honorees exemplify what it means to be a true pioneer in the pursuit to advance open and endovascular surgery and improve patient outcomes.” Professor Greenhalgh is Emeritus Professor of Surgery and Head of Imperial College London Vascular Research Group and Chairman of the Charing Cross Symposium.

“Since the Pioneers in Performance program began, physicians from all over the world have been given the opportunity to honor the extraordinary achievements of their peers and this year is no different,” said David Abeyta, Leader of the Gore Medical Products Division. “We congratulate this latest group of European-based honorees and thank them, and their fellow nominees, for their unrelenting dedication to advancing vascular and endovascular therapy for their patients and their peers.”

About W. L. Gore & Associates: The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac, and general surgery. Gore is one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.

GORE® and designs are trademarks of W. L. Gore & Associates. AT0977-EN1

In its 36th year, the Charing Cross International Symposium, held in London, is an educational forum, which takes place over four days. The plenary sessions run in a logical sequence starting with carotids and the lower limb on Saturday, the abdominal aorta on Sunday, the thoracic aorta and more carotids on Monday, renals and venous on Tuesday. Once again, a world class faculty discusses controversial topics, challenges the evidence, and takes part in a series of head-to-head debates to reach a consensus after discussion. www.cxsymposium.com.

Chempetitive Group for W. L. Gore & Associates
Rachel Lear
+1 781 775 3640
Contact by email